Public Citizen, an advocacy group, has urged the FDA to postpone its decision on whether to approve Leqembi while the companies finish the additional clinical trials needed for full approval.

Source: https://thesource.com/2023/01/10/fda-approves-new-alzheimers-drug-designed-to-slow-cognitive-decline/?utm_source=rss&utm_medium=rss&utm_campaign=fda-approves-new-alzheimers-drug-designed-to-slow-cognitive-decline

Susan Harley, Congress Watch managing director at Public Citizen, said “we’re outgunned as far as money being spent, but we have the moral higher ground” in supporting the free-file program over third-party tax preparers.

Source: https://federalnewsnetwork.com/business-news/2023/07/irs-steps-toward-a-new-free-file-tax-return-system-have-both-supporters-and-critics-mobilizing/